Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases
Tweetable abstract This work describes novel evidence of the relationship between NSAIDs and three prostaglandin E2 synthases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 15(2023), 17 vom: 03. Sept., Seite 1549-1552 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ruan, Ke-He [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 24.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2023-0172 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36199334X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36199334X | ||
| 003 | DE-627 | ||
| 005 | 20231226090318.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2023-0172 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM36199334X | ||
| 035 | |a (NLM)37702004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ruan, Ke-He |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 24.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Tweetable abstract This work describes novel evidence of the relationship between NSAIDs and three prostaglandin E2 synthases | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a NSAIDs | |
| 650 | 4 | |a PGE2 | |
| 650 | 4 | |a PGE2 synthase | |
| 650 | 4 | |a anti-inflammation | |
| 650 | 4 | |a cPGES | |
| 650 | 4 | |a mPGES-1 | |
| 650 | 4 | |a mPGES-2 | |
| 650 | 4 | |a prostaglandin E2 | |
| 650 | 7 | |a Prostaglandin-E Synthases |2 NLM | |
| 650 | 7 | |a EC 5.3.99.3 |2 NLM | |
| 650 | 7 | |a Dinoprostone |2 NLM | |
| 650 | 7 | |a K7Q1JQR04M |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a Cyclooxygenase 2 |2 NLM | |
| 650 | 7 | |a EC 1.14.99.1 |2 NLM | |
| 700 | 1 | |a Lu, Renzhong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 15(2023), 17 vom: 03. Sept., Seite 1549-1552 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:17 |g day:03 |g month:09 |g pages:1549-1552 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0172 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 17 |b 03 |c 09 |h 1549-1552 | ||